B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Thymalfasin

55 PubMed studies analyzed ยท 6 RCTs ยท Evidence Score: 52.6

Research Domains

Thymalfasin has been studied across 12 research domains including ๐Ÿ›ก๏ธ Immunity, ๐Ÿ”ฌ Oncology, ๐Ÿซ Liver & Detox, ๐Ÿ”ฌ Inflammation, ๐Ÿซ˜ Kidney. The primary research focus is ๐Ÿ›ก๏ธ Immunity with 35% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thymalfasin is generated deterministically from 55 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). ยฉ 2026 Organiq Sweden AB.